pharmaceutical investing Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
pharmaceutical investing Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch,
EnerCom Announces Initial List of Presenting Companies for the 31st Annual Energy Investment Conference to be held August 17-19, 2026, in Denver, Colorado